维普中文期刊产品整合服务
21篇 您的检索式:作者名="Nso"
    题名 作者 年代 出处 被引量
1Current systematic reviews and meta-analyses of COVID-19显示文摘BACKGROUND Coronavirus disease 2019(COVID-19)has left a significant impact on the world's health,economic and political systems;as of November 20,2020,more than 57 million people have been infected worldwide,with over 1.3 million deaths.While the global spotlight is currently focused on combating this pandemic through means ranging from finding a treatment among existing therapeutic agents to inventing a vaccine that can aid in halting the further loss of life.AIM To collect all systematic reviews and meta-analyses published related to COVID-19 to better identify available evidence,highlight gaps in knowledge,and elucidate further meta-analyses and umbrella reviews that are yet to be performed.METHODS We explored studies based on systematic reviews and meta-analyses with the keyterms,including severe acute respiratory syndrome(SARS),SARS virus,coronavirus disease,COVID-19,and SARS coronavirus-2.The included studies were extracted from Embase,Medline,and Cochrane databases.The publication timeframe of included studies ranged between January 01,2020,to October 30,2020.Studies that were published in languages other than English were not considered for this systematic review.The finalized full-text articles are freely accessible in the public domain.RESULTS Searching Embase,Medline,and Cochrane databases resulted in 1906,669,and 19 results,respectively,that comprised 2594 studies.515 duplicates were subsequently removed,leaving 2079 studies.The inclusion criteria were systematic reviews or meta-analyses.860 results were excluded for being a review article,scope review,rapid review,panel review,or guideline that produced a total of 1219 studies.After screening articles were categorized,the included articles were put into main groups of clinical presentation,epi-demiology,screening and diagnosis,severity assessment,special populations,and treatment.Subsequently,there was a second subclassification into the following groups:gastrointestinal,cardiovascular,neurological,stroke,thrombosis,anosmia and dysgeusia,ocular manifestations,nephrology,cutaneous manifestations,D-dimer,lymphocyte,anticoagulation,antivirals,convalescent plasma,immunosuppressants,corticosteroids,hydroxychloroquine,renin-angiotensin-aldosterone system,technology,diabetes mellitus,obesity,pregnancy,children,mental health,smoking,cancer,and transplant.CONCLUSION Among the included articles,it is clear that further research is needed regarding treatment options and vaccines.With more studies,data will be less heterogeneous,and statistical analysis can be better applied to provide more robust clinical evidence.This study was not designed to give recommendations regarding the management of COVID-19.Mahmoud Nassar Nso Nso Mostafa Alfishawy Anastasia Novikov Salim Yaghi Luis Medina Bahtiyar Toz Sofia Lakhdar Zarwa Idrees Yungmin Kim Dawa Ongyal Gurung Raheel S Siddiqui David Zheng Mariam Agladze Vikram Sumbly Jasmine Sandhu Francisco Cuevas Castillo Nadya Chowdhury Ravali Kondaveeti Sakil Bhuiyan Laura Guzman Perez Riki Ranat Carlos Gonzalez Harangad Bhangoo John Williams Alaa Eldin Osman Joyce Kong Jonathan Ariyaratnam Mahmoud Mohamed Ismail Omran Mariely Lopez Akwe Nyabera Ian Landry Saba Iqbal Anoosh Zafar Gondal Sameen Hassan Ahmed Daoud Bahaaeldin Baraka Theo Trandafirescu Vincent Rizzo 2021World Journal of Virology2021,10,4:2
2ABO incompatibility in renal transplantation显示文摘ABO blood group incompatibility(ABO-I)was historically considered an absolute contraindication to kidney transplantation due to the significant risk of acute antibody-mediated rejection and early graft loss.Nevertheless,the urge to minimize the gap between the candidates’number on the waitlist for kidney transplants and the available kidney donors encourage investigation into finding ways to use organs from ABO-I kidney donors,especially in the era of using more potent immunosuppression therapies.This review aims to discuss a general overview of ABO-I kidney transplantation and the different protocols adopted by some transplant centers to meaningfully overcome this barrier.Mahmoud Mohamed Tara Sweeney Duaa Alkhader Mahmoud Nassar Ahmed Alqassieh Sofia Lakhdar Nso Nso Tibor Fulop Ahmed Daoud Karim M Soliman 2021World Journal of Transplantation2021,11,9:2
3Detection of Toxoplasma gondii in eerebrnspinal fluid from AIDS patients by nested PCR and rapid identification of type I allele at B1 gene by RFLP analysis显示文摘Alfi)nso Y Fraga J Jimb:nez N et cd 2009Exp Parasitol2009,122,3:1
4Determination of linezolid in growth media by high-performance liquid chromatography with online extraction显示文摘Ba BB Nso BBB Quentin C 2007J Chromatog B2007,854,:1
5Ventricular tachycardia induced cardiomyopathy:iatm:ovemet with radiofrequency ablation显示文摘Jaggarao Nso Nanda As Daubert JP 1996PACE1996,19,:1
6Cloning and characterization of smeT,a repressor of the Stenotrophomonas maltophilia multidrug efflux pump smeDEF显示文摘Sanchez P Alo nso A Mar tinez JL 2002Antimi-crob A gent Chemother2002,46,11:1
7Extraction and purification of beta-amylase from stems of Abrus precatorius by three phase partitioning显示文摘SAGU S T NSO E J HOMANN T 2015Food Chemistry2015,183,:1
8Mortality rate of COVID-19 infection in end stage kidney disease patients on maintenance hemodialysis:A systematic review and meta-analysis显示文摘BACKGROUND Coronavirus disease 2019(COVID-19)has been the most talked-about disease of the past few years.Patients with significant comorbidities have been at particular risk of adverse outcomes.This study looked at the outcomes and risk factors for adverse outcomes among patients on chronic hemodialysis for end-stage renal disease,a group of patients known to be particularly susceptible to infectious complications.AIM To assess outcomes and risk factors for adverse outcomes of COVID-19 infection among patients on chronic hemodialysis.METHODS We searched PubMed/MEDLINE,EMBASE,Reference Citation Analysis(http://gffzzb1f9d057b5954674sfxuf5fxnobbf660c.ffgz.tsg.suse.edu.cn/)and Web of Science databases for relevant terms and imported the results into the Covidence platform.From there,studies were assessed in two stages for relevance and quality,and data from studies that satisfied all the requirements were extracted into a spreadsheet.The data was then analyzed descriptively and statistically.RESULTS Of the 920 studies identified through the initial database search,only 17 were included in the final analysis.The studies included in the analysis were mostly carried out during the first wave.We found that COVID-19 incidence among patients on hemodialysis was significant,over 10%in some studies.Those who developed COVID-19 infection were most likely going to be hospitalized,and over 1 in 5 died from the infection.Intensive care unit admission rate was lower than the infection lethality rate.Biochemical abnormalities and dyspnea were generally reported to be associated with adverse outcomes.CONCLUSION This systematic review confirms that patients on chronic hemodialysis are very high-risk individuals for COVID-19 infections,and a significant proportion was infected during the first wave.Their prognosis is overall much worse than in the general population,and every effort needs to be made to decrease their exposure.Ivan Cancarevic Mahmoud Nassar Ahmed Daoud Hatem Ali Nso Nso Angelica Sanchez Avish Parikh Asma Ul Hosna Bhavana Devanabanda Nazakat Ahmed Karim M Soliman 2022World Journal of Virology2022,11,5:1
9Acute neonatal parotitis due to Streptococcus agalactiae 显示文摘Nso Roca AP Baquero-Artigao F Garcia-Miguel MJ 2007An Pediatr (Barc)2007,67,:1
10Evolutive study of children with diffuse mesangial sclerosis显示文摘Nso Roca AP Pefia Carri6n A Benito Guti6rrez M 2009Pediatr Neph- rol2009,24,5:1
11Optimisation of low temperatur extraction of banana juice using commercial pectinase显示文摘AAGU S T NSO E J KARMAKAR S 2014Food Chemistry2014,150,:1
12Determination of linezolid ingrowth media by high-performance liquid chromatography with on-line extraction显示文摘Ba BB Nso BB Quentin C 2007J Chromatogr B2007,854,:1
13Staphylococcal scal- ded skin syndrome 显示文摘NSO A ROCA P BAQUERO-ARTIGAO F 2008Anales de Pediatr2008,68,2:1
14Optimisation of low temperature extraction of banana juice using commercial pectinase显示文摘Sorel Tchewonpi Sagu Emmanuel Jong Nso Sankha Karmakar Sirshendu De 2014Food Chemistry2014,,:1
15Optimisation of low temperature extraction of banana juice using commercial pectinase显示文摘SAGU S T NSO E J KARMAKAR S 2014Food Chemistry2014,151,:1
16Optimisation of lowtemperature extraction of banana juice usingcommercial pectinase 显示文摘Sorel Tchewonpi Sagu Emmanuel Jong Nso Sankha Karmakar 2014Food Chemistry2014,151,15:1
17Cardiac adverse events of immune checkpoint inhibitors in oncology patients:A systematic review and meta-analysis显示文摘BACKGROUND Immune checkpoint inhibitors(ICIs)are novel therapeutic agents used for various types of cancer.ICIs have revolutionized cancer treatment and improved clinical outcomes among cancer patients.However,immune-related adverse effects of ICI therapy are common.Cardiovascular immune-related adverse events(irAEs)are rare but potentially life-threatening complications.AIM To estimate the incidence of cardiovascular irAEs among patients undergoing ICI therapy for various malignancies.METHODS We conducted this systematic review and meta-analysis by searching PubMed,Cochrane CENTRAL,Web of Science,and SCOPUS databases for relevant interventional trials reporting cardiovascular irAEs.We performed a single-arm meta-analysis using OpenMeta[Analyst]software of the following outcomes:Myocarditis,pericardial effusion,heart failure,cardiomyopathy,atrial fibrillation,myocardial infarction,and cardiac arrest.We assessed the heterogeneity using the I2 test and managed to solve it with Cochrane’s leave-one-out method.The risk of bias was performed with the Cochrane’s risk of bias tool.RESULTS A total of 26 studies were included.The incidence of irAEs follows:Myocarditis:0.5%[95%confidence interval(CI):0.1%-0.9%];Pericardial effusion:0.5%(95%CI:0.1%-1.0%);Heart failure:0.3%(95%CI:0.0%-0.5%);Cardiomyopathy:0.3%(95%CI:-0.1%-0.6%);atrial fibrillation:4.6%(95%CI:1.0%-14.1%);Myocardial infarction:0.4%(95%CI:0.0%-0.7%);and Cardiac arrest:0.4%(95%CI:0.1%-0.8%).CONCLUSION The most common cardiovascular irAEs were atrial fibrillation,myocarditis,and pericardial effusion.Although rare,data from post market surveillance will provide estimates of the long-term prevalence and prognosis in patients with ICIassociated cardiovascular complications.Nso Nso Daniel Antwi-Amoabeng Bryce D Beutler Mark B Ulanja Jasmine Ghuman Ahmed Hanfy Joyce Nimo-Boampong Sirri Atanga Rajkumar Doshi Sostanie Enoru Nageshwara Gullapalli 2020World Journal of Cardiology2020,12,11:0
18New onset hypertension after transplantation显示文摘It has been reported that up to 90%of organ transplant recipients have suboptimal blood pressure control.Uncontrolled hypertension is a well-known culprit of cardiovascular and overall morbidity and mortality.In addition,rigorous control of hypertension after organ transplantation is a crucial factor in prolonging graft survival.Nevertheless,hypertension after organ transplantation encompasses a broader range of causes than those identified in non-organ transplant patients.Hence,specific management awareness of those factors is mandated.An in-depth understanding of hypertension after organ transplantation remains a debatable issue that necessitates further clarification.This article provides a comprehensive review of the prevalence,risk factors,etiology,complications,prevention,and management of hypertension after organ transplantation.Mahmoud Nassar Nso Nso Sofia Lakhdar Ravali Kondaveeti Chandan Buttar Harangad Bhangoo Mahmoud Awad Naveen Siddique Sheikh Karim M Soliman Most Sirajum Munira Farshid Radparvar Vincent Rizzo Ahmed Daoud 2022World Journal of Transplantation2022,12,3:0
19Liver kidney crosstalk:Hepatorenal syndrome显示文摘The dying liver causes the suffocation of the kidneys,which is a simplified way of describing the pathophysiology of hepatorenal syndrome(HRS).HRS is characterized by reversible functional renal impairment due to reduced blood supply and glomerular filtration rate,secondary to increased vasodilators.Over the years,HRS has gained much attention and focus among hepatologists and nephrologists.HRS is a diagnosis of exclusion,and in some cases,it carries a poor prognosis.Different classifications have emerged to better understand,diagnose,and promptly treat this condition.This targeted review aims to provide substantial insight into the epidemiology,pathophysiology,diagnosis,and management of HRS,shed light on the various milestones of this condition,and add to our current understanding.Mahmoud Nassar Nso Nso Luis Medina Victoria Ghernautan Anastasia Novikov Alli El-Ijla Karim M Soliman Yungmin Kim Mostafa Alfishawy Vincent Rizzo Ahmed Daoud 2021World Journal of Hepatology2021,13,9:0
20Liver transplantation during global COVID-19 pandemic显示文摘The coronavirus disease 2019(COVID-19)caused by severe acute respiratory disease respiratory syndrome coronavirus-2 has significantly impacted the health care systems globally.Liver transplantation(LT)has faced an unequivocal challenge during this unprecedented time.This targeted review aims to cover most of the clinical issues,challenges and concerns about LT during the COVID-19 pandemic and discuss the most updated literature on this rapidly emerging subject.Mostafa Alfishawy Nso Nso Mahmoud Nassar Jonathan Ariyaratnam Sakil Bhuiyan Raheel S Siddiqui Matthew Li Howard Chung Amira Al Balakosy Ahmed Alqassieh Tibor Fülöp Vincent Rizzo Ahmed Daoud Karim M Soliman 2021World Journal of Clinical Cases2021,9,23:0
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费